In our next ESWT live webinar »A Practical Introduction to ESWT and Sonography: Lower Extremity« Dr Jens Lundgren (DN) will share his knowledge and practical experiences with ultrasound imaging and shock wave treatment.
STORZ MEDICAL AG has been nominated together with the Berlinger Group and Sensirion AG for this year's Export Award. Every year, the prize of Switzerland Global Enterprise (S-GE) honours a company, that has developed a market development strategy tailored to its target markets, that has a clear unique selling point for its own products in international business and that is agile in dealing with export hurdles.
In September 2020, the 100th MAGNETOLITH® was ordered and delivered to Dr Damian Görner from the Steglitz Spine and Joints Centre in Berlin. In an interview, the specialist for orthopaedics and trauma surgery explains why he decided to use MAGNETOLITH®, which indications he treats and how EMTT® and ESWT complement each other.
In our next webinar Prof. Dr Matthias Beck will talk about »The Greater Trochanteric Pain Syndrome«. The Greater Trochanteric Pain Syndrome (GTPS) is related to the tendinopathy (tendinosis, partial- and full-thickness tears) of the muscles which inserts at the greater trochanter of the femur. In addition to these degenerative changes in the tendons inflammation of the synovial bursae could be a reason for the pain in the gluteal area which is elicited by rotational hip movements and lateral position.
In 2019 the NEUROLITH® shock wave system was successfully introduced to the market. The Transcranial Pulse Stimulation (TPS) device, which was developed by STORZ MEDICAL in Switzerland, is the only medical device marketed in Europe that is approved in the European Union for the treatment of the central nervous system of patients with Alzheimer's disease. The effect of TPS is now being investigated in another neurological condition: In September 2020, the world's first clinical study for the treatment of Parkinson's patients with shock wave therapy using real-time documentation started at MedUni Vienna (Department of Neurology) in Austria under the direction of Professor Roland Beisteiner.